Philips Expands Remote Patient Monitoring with Six New Tech Partnerships
In August 2026, Royal Philips expanded its open patient monitoring network by partnering with six health technology firms, including Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare. The integrated technologies help health systems track patients continuously outside traditional hospital beds, supporting coordinated care and smooth transitions from hospital care to recovery at home.
How Philips is Redefining Remote Patient Monitoring
As healthcare systems expand higher-acuity services beyond traditional hospitals, maintaining visibility into patient status across the care continuum is crucial. Philips is leading this shift with an interoperable monitoring ecosystem that enables health systems to deploy and scale monitoring programs based on clinical and operational needs. Philips also transforms it into actionable insights by connecting patient data across various care settings and accelerating care coordination throughout the patient's journey.
Sangdo Kim, Category Leader at Philips, emphasized that healthcare organizations demand a more connected approach, helping clinicians maintain visibility into patient status across care settings. The partnerships enhance Philips' ecosystem with continuous patient measurement integrations of new wearable devices and out-of-hospital systems, including:
- Blue Spark Technologies: TempTraq, a wearable patch for continuous temperature monitoring.
- Caretaker Medical: VitalStream for continuous non-invasive blood pressure and hemodynamic monitoring.
- Cuviva: A platform enabling structured hospital-at-home care with digital monitoring and integration with clinical workflows.
- LifeSignals: UbiqVue, a wearable biosensor for monitoring multiple vital signs.
- Respiree: It is a 1Bio platform for cardio-respiratory monitoring.
- smartQare: viQtor and Healthdot technologies for continuous monitoring of vital signs and activity.
These capabilities complement Philips' connected care portfolio, including Mobile Cardiac Telemetry (MCOT), which allows remote monitoring of cardiac patients post-discharge. By combining enterprise monitoring with innovative partners, Philips is shaping the future of continuous patient monitoring across the care continuum.
Impact on the Healthcare Industry
This partnership positively impacts the healthcare industry by integrating third-party wearables and out-of-hospital tools into platforms like the Philips Patient Information Center iX, shifting fragmented remote data into continuous, actionable clinical intelligence from hospital to home.
This technology contributes to the healthcare industry by continuous multi-parameter telemetry transformation healthcare from isolated bedside monitoring to ongoing patient tracking across the entire care journey. This also enables early deterioration detection for vital signs like ECG and blood pressure, allowing doctors to act faster and reduce avoidable hospital readmissions after discharge.
Health systems can use these remote tools to scale hospital-at-home care with confidence. This setup allows providers safely manage complex chronic and post-acute patients outside traditional facilities while maintaining a steady line of sight on recovering individuals.
This move generally addresses industry hurdles by standardizing fragmented sensor feeds into unified hospital dashboards, embedding external wearable data directly into clinical workflows to reduce friction, and leveraging a vendor-neutral design to avoid hardware lock-in. This approach lets hospitals easily integrate diverse third-party devices and choose specialized equipment for different patient groups without being restricted to a single device maker.

Impact on the Remote Patient Monitoring Systems Industry
The global remote patient monitoring systems market size accounted for USD 8.68 billion in 2025 and is predicted to increase from USD 10.29 billion in 2025 to approximately USD 43.88 billion by 2035, growing at a CAGR of 17.59% from 2026 to 2035.
According to Precedence Research, this partnership benefits the industry by transforming care from episodic to continuous, longitudinal tracking from hospital to home by connecting data gaps during critical patient transitions.
This technology transforms the industry by extending real-time patient vital tracking from hospital beds into home recovery settings. It combines diverse data streams, such as temperature patches, blood pressure monitors, and ECG markers, directly into central dashboards like the Patient Information Center (PIC) iX.
This further scales hospital-at-home models by standardizing workflows for decentralized acute care, along with the hospitals to safely monitor higher-acuity patients outside traditional walls by increasing operational efficiency and expanding remote patient management capabilities.
This further overcomes workflow and data fragmentation by implementing a vendor-neutral, open ecosystem that integrates diverse third-party biosensors directly into existing hospital IT systems. This move mitigates data silos and enables continuous streaming of predictive, multi-parameter data for clinical teams to identify patient deterioration early and prevent emergency readmissions.
About Royal Philips
Royal Philips transitioned from consumer electronics to become a pure-play health technology leader that is headquartered in Amsterdam. It targets the entire health continuum from prevention to home care, including expanded care access for 400 million people in underserved communities through AI-driven and integrated platforms.
The company operates across three main domains: diagnosis and treatment, including precision imaging, ultrasound, and image-guided therapy; Connected Care, such as patient monitoring, informatics, and sleep and respiratory care; and personal health with advanced AI-enabled oral healthcare products like smart power toothbrushes.